...
hook-img

Hookipa Pharma Inc, Common Stock

HOOK

NAQ

$2.13

-$0.01

(-0.47%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$26.76M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
80.05K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.83
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.88 L
$11.3 H
$2.13

About Hookipa Pharma Inc, Common Stock

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-200 for the treatment of pembrolizumab which is in Phase 2 of clinical trial; HB-700, a preclinical development for treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers. Its lead product candidates are HB-400 for the treatment of Hepatitis B which is in Phase I of clinical trial and HB-500 for the treatment of HIV which is in Phase I of clinical trial. The company's preclinical stage products include HB-300 program for prostate cancer. It has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameHOOKSectorS&P500
1-Week Return-15.14%-2.27%-0.57%
1-Month Return-37.72%-3.96%1.21%
3-Month Return-57.31%-9.7%7.57%
6-Month Return-72.76%-3.37%11.45%
1-Year Return-67.48%3.71%28.48%
3-Year Return-92.31%3.8%29.52%
5-Year Return-97.22%39.78%90.66%
10-Year Return-98.48%106.91%203.75%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue11.94M19.58M18.45M14.25M20.13M[{"date":"2019-12-31","value":59.33,"profit":true},{"date":"2020-12-31","value":97.29,"profit":true},{"date":"2021-12-31","value":91.65,"profit":true},{"date":"2022-12-31","value":70.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue46.31M53.13M4.64M3.60M3.55M[{"date":"2019-12-31","value":87.16,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":8.73,"profit":true},{"date":"2022-12-31","value":6.78,"profit":true},{"date":"2023-12-31","value":6.69,"profit":true}]
Gross Profit11.94M19.58M18.45M14.25M16.58M[{"date":"2019-12-31","value":60.98,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":94.2,"profit":true},{"date":"2022-12-31","value":72.76,"profit":true},{"date":"2023-12-31","value":84.65,"profit":true}]
Gross Margin100.00%100.00%100.00%100.00%82.35%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.35,"profit":true}]
Operating Expenses63.03M72.87M100.12M87.40M117.82M[{"date":"2019-12-31","value":53.49,"profit":true},{"date":"2020-12-31","value":61.85,"profit":true},{"date":"2021-12-31","value":84.98,"profit":true},{"date":"2022-12-31","value":74.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(51.09M)(53.28M)(81.67M)(73.16M)(97.69M)[{"date":"2019-12-31","value":-5108500000,"profit":false},{"date":"2020-12-31","value":-5328500000,"profit":false},{"date":"2021-12-31","value":-8167400000,"profit":false},{"date":"2022-12-31","value":-7315500000,"profit":false},{"date":"2023-12-31","value":-9769400000,"profit":false}]
Total Non-Operating Income/Expense8.76M8.82M5.14M9.19M21.07M[{"date":"2019-12-31","value":41.57,"profit":true},{"date":"2020-12-31","value":41.85,"profit":true},{"date":"2021-12-31","value":24.39,"profit":true},{"date":"2022-12-31","value":43.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(43.04M)(44.08M)(75.67M)(64.92M)(81.21M)[{"date":"2019-12-31","value":-4303700000,"profit":false},{"date":"2020-12-31","value":-4408200000,"profit":false},{"date":"2021-12-31","value":-7566500000,"profit":false},{"date":"2022-12-31","value":-6491500000,"profit":false},{"date":"2023-12-31","value":-8121200000,"profit":false}]
Income Taxes(8.89M)(10.28M)1.00K230.00K368.00K[{"date":"2019-12-31","value":-2415.76,"profit":false},{"date":"2020-12-31","value":-2793.75,"profit":false},{"date":"2021-12-31","value":0.27,"profit":true},{"date":"2022-12-31","value":62.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(34.15M)(33.80M)(75.67M)(65.14M)(81.58M)[{"date":"2019-12-31","value":-3414700000,"profit":false},{"date":"2020-12-31","value":-3380100000,"profit":false},{"date":"2021-12-31","value":-7566600000,"profit":false},{"date":"2022-12-31","value":-6514500000,"profit":false},{"date":"2023-12-31","value":-8158000000,"profit":false}]
Income From Continuous Operations(43.04M)(44.08M)(75.67M)(64.92M)(69.07M)[{"date":"2019-12-31","value":-4303700000,"profit":false},{"date":"2020-12-31","value":-4408200000,"profit":false},{"date":"2021-12-31","value":-7566500000,"profit":false},{"date":"2022-12-31","value":-6491500000,"profit":false},{"date":"2023-12-31","value":-6907300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(34.15M)(33.80M)(75.67M)(65.14M)(81.58M)[{"date":"2019-12-31","value":-3414700000,"profit":false},{"date":"2020-12-31","value":-3380100000,"profit":false},{"date":"2021-12-31","value":-7566600000,"profit":false},{"date":"2022-12-31","value":-6514500000,"profit":false},{"date":"2023-12-31","value":-8158000000,"profit":false}]
EPS (Diluted)(10.75)(1.70)(2.31)(1.05)(0.88)[{"date":"2019-12-31","value":-1075,"profit":false},{"date":"2020-12-31","value":-170,"profit":false},{"date":"2021-12-31","value":-231,"profit":false},{"date":"2022-12-31","value":-105,"profit":false},{"date":"2023-12-31","value":-88,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HOOK
Cash Ratio 2.09
Current Ratio 3.26

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HOOK
ROA (LTM) -20.10%
ROE (LTM) -48.99%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HOOK
Debt Ratio Lower is generally better. Negative is bad. 0.35
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.65

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HOOK
Trailing PE NM
Forward PE NM
P/S (TTM) 0.51
P/B 0.36
Price/FCF NM
EV/R 1.91
EV/Ebitda 0.46

FAQs

What is Hookipa Pharma Inc share price today?

Hookipa Pharma Inc (HOOK) share price today is $2.13

Can Indians buy Hookipa Pharma Inc shares?

Yes, Indians can buy shares of Hookipa Pharma Inc (HOOK) on Vested. To buy Hookipa Pharma Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HOOK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Hookipa Pharma Inc be purchased?

Yes, you can purchase fractional shares of Hookipa Pharma Inc (HOOK) via the Vested app. You can start investing in Hookipa Pharma Inc (HOOK) with a minimum investment of $1.

How to invest in Hookipa Pharma Inc shares from India?

You can invest in shares of Hookipa Pharma Inc (HOOK) via Vested in three simple steps:

  • Click on Sign Up or Invest in HOOK stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Hookipa Pharma Inc shares
What is Hookipa Pharma Inc 52-week high and low stock price?

The 52-week high price of Hookipa Pharma Inc (HOOK) is $11.3. The 52-week low price of Hookipa Pharma Inc (HOOK) is $1.88.

What is Hookipa Pharma Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Hookipa Pharma Inc (HOOK) is

What is Hookipa Pharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Hookipa Pharma Inc (HOOK) is 0.36

What is Hookipa Pharma Inc dividend yield?

The dividend yield of Hookipa Pharma Inc (HOOK) is 0.00%

What is the Market Cap of Hookipa Pharma Inc?

The market capitalization of Hookipa Pharma Inc (HOOK) is $26.76M

What is Hookipa Pharma Inc’s stock symbol?

The stock symbol (or ticker) of Hookipa Pharma Inc is HOOK

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top